Powder: -20°C for 3 years | In solvent: -80°C for 1 year
VU0119498 is a M1 muscarinic receptor agonist (EC50 = 3.1 μM) and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
10 mg | In stock | $ 48.00 | |
25 mg | In stock | $ 88.00 | |
50 mg | In stock | $ 134.00 | |
100 mg | In stock | $ 198.00 | |
200 mg | In stock | $ 297.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 55.00 |
Description | VU0119498 is a M1 muscarinic receptor agonist (EC50 = 3.1 μM) and pan mAChR M3, M5 positive allosteric modulator (PAM),and is a neuroprotective agent. |
Targets&IC50 | M1:3.1 μM(EC50) |
In vivo | VU0119498 treatment of wild-type mice caused a significant increase in plasma insulin levels, accompanied by a striking improvement in glucose tolerance |
Molecular Weight | 316.15 |
Formula | C15H10BrNO2 |
CAS No. | 79183-37-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 15 mg/mL (47.45 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
VU0119498 79183-37-2 Neuroscience AChR antidiabetic Inhibitor VU-0119498 inhibit mAChR VU 0119498 pan Muscarinic acetylcholine receptor inhibitor